Baljiwan Medicines Private Limited

Baljiwan Medicines Private Limited - healthcare in Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U24231UP1989PTC011170 Incorporated 14 September 1989 ROC Kanpur HQ Uttar Pradesh, India
Active Private Limited Company healthcare MSME · Micro
Revenue · FY 2021
₹2.96 Cr
▲ 26% YoY
Net profit · FY 2021
₹4.68 Lakh
Net margin 1.6%
EBITDA · FY 2021
₹26.56 Lakh
EBITDA margin 9%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹13 Lakh
Issued & subscribed
Open charges
₹1.23 Cr
Satisfied ₹52.5 Lakh
Company age
37 yrs
Est. 1989
Employees · EPFO
22
Provident fund records

About Baljiwan Medicines Private Limited

Data last updated:

Baljiwan Medicines Private Limited is a private limited company based in Uttar Pradesh, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 14 September 1989 and has been in existence for over 37 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24231UP1989PTC011170. Its GSTIN is 09AAACB6510F1Z2 (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹13 Lakh. It is led by directors Saurabh Agarwal and Richa Agrawal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5th K.M Delhi Road Nearsarsauli Aligarh, Uttar Pradesh, India.

As per the financials filed for FY 2021, the company reported a revenue of ₹2.96 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹4.68 Lakh (net margin 1.6%) and EBITDA of ₹26.56 Lakh (EBITDA margin 9%). Revenue has declined at a compounded annual rate (CAGR) of 1% over five years.

The company has about 22 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹1.23 Cr and satisfied charges of ₹52.5 Lakh on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending.

Baljiwan Medicines Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-02-0000473). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website baljiwan.com.

Company details

CIN U24231UP1989PTC011170
Registration Number 011170
Incorporation Date 14 September 1989
ROC Kanpur
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-02-0000473

Recognitions & Rankings of Baljiwan Medicines

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-UP-02-0000473

Contact details

Baljiwan Medicines Private Limited's registered office is in Uttar Pradesh. Its website is baljiwan.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    5th K.M Delhi Road Nearsarsauli Aligarh, Uttar Pradesh, India
  • Industry
    Healthcare, Ayurvedic Products & Services

To see the full contact details of Baljiwan Medicines Private Limited, buy the company report.

Comprehensive company report
Baljiwan Medicines Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Baljiwan Medicines Private Limited

FY 2025 filings available

Baljiwan Medicines Private Limited reported revenue of ₹2.96 Cr (up 26% YoY) for FY 2021.

Revenue · FY 2021
₹2.96 Cr ▲ 26%
Net profit · FY 2021
₹4.68 Lakh margin 1.6%
EBITDA · FY 2021
₹26.56 Lakh margin 9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 26%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▲ 50%
3 years · compounded
▲ 34%
5 years · compounded
▲ 13%

Revenue rose 26% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹2.96 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹26.56 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹4.68 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin9%
Net Profit Margin1.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Baljiwan Medicines Private Limited, buy the company report.

Board of directors of Baljiwan Medicines Private Limited

Baljiwan Medicines has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Saurabh AgarwalDirector20 Apr 201511 Years 7 MonthsCurrent
Richa AgrawalDirector20 Apr 201511 Years 7 MonthsCurrent

Auditor

Baljiwan Medicines Private Limited is audited by AVAN & ASSOCIATES for the financial year 2021.

Auditor firmFinancial yearFirm registration number
AVAN & ASSOCIATESFY 2021007305C

Shareholding

The shareholding of Baljiwan Medicines Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Baljiwan Medicines Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.23 Cr
Satisfied charges
₹52.5 Lakh
Breakdown by lending institutions
Canara Bank₹1.23 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
10 Jun 2022100583720Canara Bank₹10 LakhOpen
21 Aug 2017100119720Canara Bank₹12.5 LakhOpen
21 Aug 2017100119729Canara Bank₹1 CrOpen
15 Apr 2020100341096Canara Bank₹35 LakhSatisfied
31 Mar 2018100176408Canara Bank₹17.5 LakhSatisfied

To see the full charge records of Baljiwan Medicines Private Limited, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Baljiwan Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Baljiwan Medicines has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
09AAACB6510F1Z2Uttar PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Baljiwan Medicines Private Limited, buy the company report.

Recent activity

Baljiwan Medicines Private Limited has 8 board changes on record since 2010: 2 appointments and 6 cessations. The latest: Sarvesh Agarwal ceased to be Director on 08 Nov 2023.

AGM
Baljiwan Medicines Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Baljiwan Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Sarvesh Agarwal ceased to be Director.
Charges
A charge registered on 31 Mar 2018 via Charge ID 100176408 with Canara Bank was fully satisfied on 26 Oct 2023.
Charges
A charge registered on 15 Apr 2020 via Charge ID 100341096 with Canara Bank was fully satisfied on 10 Aug 2023.
Charges
A charge with Canara Bank amounted to Rs. 10.00 Lakh with Charge ID 100583720 was registered on 10 Jun 2022.
Charges
A charge with Canara Bank amounted to Rs. 35.00 Lakh with Charge ID 100341096 was registered on 15 Apr 2020.
Charges
A charge with Canara Bank of Rs. 35.00 Lakh registered on 15 Apr 2020 with Charge ID 100341096 was modified on 15 Apr 2020.
Charges
A charge with Canara Bank of Rs. 100.00 Lakh registered on 21 Aug 2017 with Charge ID 100119729 was modified on 06 Mar 2019.
Charges
A charge with Canara Bank amounted to Rs. 17.50 Lakh with Charge ID 100176408 was registered on 31 Mar 2018.
Charges
A charge with Canara Bank amounted to Rs. 12.50 Lakh with Charge ID 100119720 was registered on 21 Aug 2017.
Charges
A charge with Canara Bank amounted to Rs. 100.00 Lakh with Charge ID 100119729 was registered on 21 Aug 2017.

8 earlier events are in the company report.

Frequently asked questions

Baljiwan Medicines is an active private limited company based in Uttar Pradesh, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 14 September 1989 (37+ years old) and is registered under CIN U24231UP1989PTC011170.

Baljiwan Medicines has 2 current directors:

The latest financial statements of Baljiwan Medicines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Baljiwan Medicines is 09AAACB6510F1Z2, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Baljiwan Medicines is U24231UP1989PTC011170. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Baljiwan Medicines has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.

Baljiwan Medicines was incorporated on 14 September 1989, making it 37+ years old. It is registered with the Registrar of Companies, Kanpur.

Sarvesh Agarwal ceased to be Director on 08 Nov 2023. Jyoti Swaroop Agarwal ceased to be Managing Director on 08 May 2016. Anita Agrawal ceased to be Director on 07 Nov 2015. Baljiwan Medicines has 8 board changes on record in total.

Yes, Baljiwan Medicines is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-02-0000473).

Baljiwan Medicines can be reached through the website baljiwan.com. Its registered office is in Uttar Pradesh, India.